Interestingly, AKT knockdown negatively affects the expression of p70S6K, an AKT effector protein involved in cell survival within the phosphatidylinositol 3-kinase (PI3K)/AKT pathway-driven ovarian cancer development [51]. The gene discussed is AKT1; the disease is ovarian cancer.